(Q42551004)

2 November 2017

title

Propafenone for conversion and prophylaxis of atrial fibrillation. Propafenone Atrial Fibrillation Trial Investigators (English)

1 reference

2 November 2017

0 references

Stroobandt R

1

1 reference

2 November 2017

Stiels B

series ordinal

2

1 reference

2 November 2017

Hoebrechts R

series ordinal

3

1 reference

2 November 2017

language of work or name

English

0 references

publication date

1 February 1997

1 reference

American Journal of Cardiology

2 November 2017

published in

1 reference

2 November 2017

volume

79

1 reference

2 November 2017

issue

4

1 reference

2 November 2017

page(s)

418-423

1 reference

Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900779-5

Sinus node-atrioventricular node isolation: long-term results with the "corridor" operation for atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900779-5

Efficacy of type 1C antiarrhythmic agents for treatment of resistant atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900779-5

Usefulness of propafenone for recurrent paroxysmal atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900779-5

Epidemiologic features of chronic atrial fibrillation: the Framingham study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900779-5

Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900779-5

Atrial fibrillation and flutter: maintaining stability of sinus rhythm versus ventricular rate control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900779-5

Effectiveness of intravenous propafenone for conversion of atrial fibrillation and flutter of recent onset

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900779-5

The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900779-5

Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900779-5

Digoxin for atrial fibrillation: a drug whose time has gone?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900779-5

Adverse reactions to quinidine in hospitalized patients: findings based on data from the Boston Collaborative Drug Surveillance Program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900779-5

10.1016/S0002-9149(96)00779-5

7 January 2021

Identifiers

DOI

1 reference

2 November 2017

1 reference